首页> 外文期刊>Rheumatology >Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
【24h】

Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation

机译:用先天性免疫抑制剂白细胞介素37治疗实验性关节炎可减轻关节和全身性炎症

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives. The IL-1 family member IL-37 was recently characterized as a fundamental inhibitor of innate inflammation. We investigated the effects of recombinant IL-37 in joint inflammation and joint pathology in a mouse model of arthritis. In addition, we explored the potential for therapeutic use in human joint inflammation.
机译:目标。 IL-1家族成员IL-37最近被表征为先天性炎症的基本抑制剂。我们调查了关节炎小鼠模型中关节炎症和关节病理中重组IL-37的影响。另外,我们探索了在人类关节发炎中治疗用途的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号